Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events - O'Neill,W.W.; Serruys,P.; Knudtson,M. (N Engl J Med, 2000)